π¨ Watchlist Update: Multiple Buy Levels Triggered
Two stocks from our Top 10 Breakout Watchlist this week have already cleared their recommended buy levels. Here’s a quick rundown:
onsemi (NASDAQ: ON) has broken out of a falling wedge pattern and cleared our buy level of $78.40. The stock closed at $80.08 β with an intraday high of $80.46 β already showing early momentum above the breakout level.
Keysight Technologies, Inc. (NYSE: KEYS) broke out of a flag pattern and pushed through our buy level of $369.60, closing at $373.88 β with an intraday high of $376.68 β holding comfortably above the breakout level.
Bottom line: Use trailing stops to lock in early gains and let the winners run. And now, on to today’s featured setupβ¦
We flagged Coherent Corp. (NYSE: COHR) in our breakout watchlist on Sunday, September 20 β and the stock just surged +10.9% in a single session to press right up against the top of a four-month symmetrical triangle. It looks poised to break out and head even higher.
As we’ll get to just ahead, the combination of a brand-new product platform built for the AI data-center boom, a multibillion-dollar partnership with the world’s leading AI chipmaker, and a chart that’s coiled right at the edge of a breakout makes COHR one of the more interesting setups on the board. Here’s what’s going onβ¦
The Themes Behind the Move
Coherent is a U.S.-based maker of lasers, optical components, and networking hardware β including the transceivers that convert electrical data signals into light and back, co-packaged optics, and optical circuit switches used in AI data centers, along with industrial lasers and engineered materials for semiconductor equipment, display manufacturing, and scientific research. Formerly known as II-VI Incorporated, the company was renamed Coherent Corp. in 2022 and is headquartered in Saxonburg, Pennsylvania.
In plain English, every time an AI data center shuttles information between thousands of chips, more and more of that data is traveling as pulses of light rather than electricity β and Coherent makes many of the lasers, light-converting modules, and optical parts that make that possible. Its business hinges on how fast the big cloud and AI players keep building capacity, how quickly the industry shifts to faster networking speeds and more tightly integrated optics, and whether Coherent can scale manufacturing fast enough to keep up with demand.
COHR’s latest move reflects a powerful confluence of developments β commercial, strategic, and policy-driven β that have come back into focus all at once, as fresh analyst coverage and renewed sector buying put the spotlight back on a growth story that has been building for months.
| Theme / Catalyst | What Happened | Why Traders Care |
|---|---|---|
| PhotonLink AI optics platform launch | On September 21, 2026, Coherent launched PhotonLink, an integrated optics platform covering co-packaged optics (CPO) and near-packaged optics (NPO) β designs that place the optical connections right next to, or inside the same package as, AI chips β plus emerging chip-to-chip connectivity. Coherent disclosed more than 10 CPO engagements, more than 10 NPO engagements, and more than five chip-to-chip engagements, with anchor customers and long-term agreements secured for CPO and NPO. Revenue is expected to begin ramping in Q4 calendar 2026. | PhotonLink moves Coherent up the value chain β from selling individual components to selling complete optical assemblies that combine lasers, silicon photonics, fibers, detectors, precision optics, and testing. That expands the dollar opportunity per AI system. The engagements don’t yet tell us how big the eventual revenue will be, but a ramp starting this quarter puts a near-term proof point squarely on the calendar. |
| NVIDIA partnership + accelerated capacity build | On March 2, 2026, NVIDIA and Coherent announced a nonexclusive, multiyear strategic agreement that includes a multibillion-dollar purchase commitment, future capacity rights for advanced lasers and optical-networking products, and a $2 billion NVIDIA investment supporting R&D and U.S. manufacturing expansion. On the Q4 earnings call, management targeted doubling internal indium phosphide (InP) output β the specialty material used to make high-speed lasers β year over year by September 30, 2026, a quarter ahead of plan, followed by another more-than-doubling by year-end 2027. On September 17, Coherent also expanded its pluggable optical line system portfolio, supporting up to 25.6 Tbps across 2β200 km links between data centers, and its optics featured in a quantum-security demonstration with CUbIQ on an NVIDIA system. | The NVIDIA deal isn’t new, but it remains the bedrock of Coherent’s demand visibility β the world’s leading AI chipmaker has committed both purchase dollars and capital. (Neither the investment nor the purchase commitment counts as immediate revenue.) Paired with a capacity build running ahead of schedule, it positions Coherent across pluggable modules, integrated optics, and data-center-to-data-center links β so it isn’t betting on a single architecture. |
| Sector tailwinds | AI networking demand is extending from 800G toward next-generation 1.6T speeds, integrated optics, and optical circuit switching (OCS) β switches that route data as light without converting it back to electricity. Citi reportedly forecasts an $11 billion OCS market by 2030, with Google and NVIDIA as key demand drivers. In Washington, a bipartisan bill introduced September 25 would restrict transceivers linked to Chinese suppliers InnoLight and Eoptolink in sensitive federal national-security systems, with a five-year transition period β part of the backdrop as Coherent and Lumentum ripped higher on October 1. | The pie is growing, and the fastest-growing slices β 1.6T, integrated optics, and optical switching β are exactly where Coherent is investing. The bill is proposed legislation, not law, and it doesn’t cover commercial hyperscaler purchases, so treat it as optional upside: any restriction on Chinese suppliers could shift share toward U.S.-based makers, though Chinese production capacity would be hard to replace quickly. |
| Record Q4 + higher near-term guidance | On August 12, 2026, Coherent reported Q4 FY2026 revenue of $2.046 billion (+33.8% YoY, +13.3% QoQ) and adjusted EPS of $1.74, topping the $1.58 consensus by roughly 10%. Full-year revenue reached $7.118 billion (+22.5%), with adjusted EPS up 58.9% to $5.61 and a Q4 adjusted operating margin of 21.8%. Q1 FY2027 guidance calls for revenue of $2.20Bβ$2.40B and adjusted EPS of $1.85β$2.05. The June 30 balance sheet showed $1.162 billion in cash plus $825 million in short-term investments against roughly $3.22 billion of debt. | Revenue is accelerating and profits are growing far faster than sales β adjusted EPS up nearly 59% on 22.5% revenue growth β a sign that operating leverage is kicking in. Guidance implies another sequential step up in both revenue and earnings, so the growth story is showing up in the numbers, not just in product announcements. |
| Analyst coverage | Consensus is Buy. Per Stock Analysis, the average 12-month price target sits at $415.36 (median $420), with a range of $280β$500 β implying roughly 30% upside from the $319.19 close on average and about 57% at the high end. Recent actions: Bernstein initiated at Outperform with a $350 target on September 30; Citi and Stifel maintained Buy at $420; Rosenblatt reiterated Buy at a Street-high $500; and Deutsche Bank initiated at Buy with a $400 target. After August earnings, JPMorgan ($465), Jefferies ($420), and Needham ($420) all raised their targets (full rating history). | A fresh initiation from a heavyweight like Bernstein β landing just as the stock bounced off major support β brings new institutional eyes to the name. The average target sits comfortably above both of our price targets, and a cluster of recent targets at $420 and above suggests most of the Street sees the four-month pullback as a pause, not a top. |
| Market conviction signal | On October 1, COHR jumped +10.9% to close at $319.19 on visibly the heaviest volume in weeks β launching from the confluence of the triangle’s lower trendline and the 200-day moving average and closing near the top of its daily range. Benzinga’s options feed also flagged a bullish sweep in long-dated December 2027 $500 calls β 100 contracts versus open interest of 55. | A near-11% move off a major support zone on heavy volume suggests buyers are stepping in with conviction rather than nibbling. The options print is small and isn’t proof of institutional accumulation on its own β but someone is willing to pay up for exposure to much higher prices over the next year-plus. |
| Upcoming triggers | Traders are watching Q1 FY2027 earnings, estimated around November 4 (consensus adjusted EPS of $1.92; Market Chameleon estimates a November 4β9 window, and the company hasn’t confirmed the date), the PhotonLink revenue ramp expected in Q4 calendar 2026, confirmation that the InP capacity doubling landed on schedule, management’s target of a first $3 billion-plus revenue quarter by June 2027, and any progress on the proposed Chinese-transceiver bill. | A staggered set of catalysts β earnings, a new product ramp, capacity milestones, and policy developments β each capable of moving the stock on its own through the rest of 2026 and into 2027. November’s report covers the quarter before the PhotonLink ramp, so forward commentary may matter more than the reported numbers. |
If needed, swipe or scroll sideways to view the full table.
Put it all together, and COHR is looking less like an AI-momentum name that has run out of steam and more like a fast-growing AI infrastructure supplier that has spent four months digesting a massive run β with accelerating earnings, a deep-pocketed anchor customer, a new product ramp starting this quarter, and a chart pressing right up against the top of its range.
The story is getting stronger, but the chart is what could determine whether this move has more room to run in the near term. Here are the bullish technical signals traders should be watching now.
Bullish Technical Signals
#1 Symmetrical Triangle Pattern: COHR has spent roughly four months coiling inside a symmetrical triangle on the daily chart, marked in purple. Lower highs have descended from the ~$440 June peak while higher lows have risen from the ~$222 late-July trough. That convergence is the market digesting a massive multi-year advance: sellers have trimmed each rally a little earlier, buyers have defended each dip a little higher, and the range has compressed accordingly. Yesterday’s session showed which side is gaining the upper hand. COHR opened at the confluence of the lower trendline and the 200-day SMA, crossed nearly the full width of the triangle in a single +10.9% session, and closed at $319.19, near the top of its daily range on visibly the heaviest volume in weeks. To be clear, the pattern has not yet resolved; the $323.23 high tested the upper trendline without clearing it. The trigger is a sustained move above ~$331.00, which would clear both the upper boundary and the mid-September swing high (the most recent lower high in the sequence) and end the run of descending peaks. With price now deep into the apex, where compression typically gives way to expansion, and the prior trend unambiguously higher, the structure favors an upside resolution.
COHR β Daily Chart
#2 Price Above 50-MA and 200-MA: COHR trades above both its 50-day SMA ($296.55) and 200-day SMA ($288.23), with the 50-day still positioned above the 200-day. That golden-cross alignment keeps the intermediate- and long-term trends pointed the same way, and it has survived a real stress test. The JulyβSeptember correction pulled the 50-day down from the ~$370 area and flattened it, yet it never crossed beneath the 200-day. The two averages now sit only ~$8 apart, and that tight convergence overlaps the triangle’s lower trendline to form a dense support band from the high-$280s to the mid-$290s. Price tested that band repeatedly through the second half of September and held each time, which is exactly where yesterday’s surge launched from. The honest nuance is that the 50-day is flat rather than rising, so this is a reset trend awaiting re-acceleration rather than a fresh one. At ~7.6% above the 50-day, though, price isn’t stretched, and a pullback toward ~$308 would retest a recent pivot without threatening the MA support beneath it.
#3 Bullish ADX and DI: The directional read favors buyers. +DI (28.77) sits above βDI (24.06), and yesterday’s surge widened the gap as +DI hooked higher while βDI rolled over. The more telling part of this signal is the ADX line itself. At 7.91, it is about as suppressed as the indicator gets: far below the 20 threshold and beneath both DI lines, the mathematical fingerprint of the triangle’s compression. A low ADX doesn’t mean weakness; it means no trend has yet taken hold. That is precisely the condition that precedes this indicator’s highest-quality signal, a turn higher from a suppressed base beneath both DI lines with +DI in control. That turn hasn’t happened yet, and a DI spread of under five points is narrow, so this reading is a setup rather than a confirmation. A decisive break above $331 should be the event that lifts ADX off the floor. Starting from single digits, there’s ample runway before the trend could be called mature.
#4 Bullish MACD: The MACD line (0.67) has crossed above its signal line (β0.87), pushing the histogram positive to +1.54. Location is what elevates this crossover. It’s firing right at the zero line, the zone that separates a reflexive bounce from a genuine momentum shift, and it coincides with the MACD line itself turning positive. In other words, the 12-day EMA has moved back above the 26-day EMA. Crossovers deep below zero tend to be early but noisy; crossovers at zero carry more conviction. After a trough near β25 in late July and most of the past six weeks spent flat-lining around zero as the triangle tightened, MACD is breaking out of its own compression just as price presses the triangle’s upper rail. Stacked against the ADX setup in #3, the message is consistent: momentum is turning first, and trend strength should follow on a confirmed breakout.
#5 Above Support Area with Price Above 50-MA and 200-MA: Zooming out, the weekly chart shows the daily triangle for what it is: a consolidation inside a powerful primary uptrend that carried COHR from the mid-$30s in late 2023 to ~$440 by mid-2026. Through the correction, price has held above the $287.79 support area (pink), near where the early-2026 advance first stalled. That makes it a resistance-turned-support level, the kind the market tends to respect. This week’s candle is a live test of it. Price undercut the level to a $275.79 intraweek low, found buyers, and has rallied to $319.19, leaving a long lower wick that signals rejection of lower prices. Beneath that, the rising 50-week SMA ($266.72) adds a second layer of defense, and it sits far above the 200-week ($114.66) in a long-established golden alignment. The July flush to ~$222 found its floor near that rising 50-week average. When the daily MAs, the triangle’s lower rail and the weekly support area all cluster in the same ~$285β$300 zone, that zone carries more weight than any one of them alone.
COHR β Weekly Chart
#6 Bullish RSI: The weekly RSI (52.91) has crossed back above both the 50 midline and its own moving average (50.96). This is a two-part read. The cross above 50 hands the momentum edge back to buyers, and the upslope through the signal average shows that edge is building rather than stalling. What makes the reading more convincing is how RSI behaved on the way down. After pushing into the 75β80 zone during the spring advance, it bottomed in the mid-40s through the correction and never broke into the sub-40 territory typical of a bear phase. Holding that floor through a sharp, nearly 50% peak-to-trough shakeout is classic bull-market behavior. The correction fully reset an overbought condition without damaging the trend’s character. At ~53, RSI has considerable room before 70 becomes a headwind.
#7 Bullish Stoch: On the weekly stochastic, %K (55.10) has crossed above %D (44.52) and is turning higher. The location matters. After an oversold dip near 20 in July, both lines spent weeks chopping in the 30β45 range, and the crossover is now coming from that neutral middle rather than from an oversold extreme. In an established uptrend, a mid-range crossover is the more meaningful signal: it reflects momentum re-engaging from a reset base rather than a reflexive snapback, and on the weekly timeframe it carries far more weight than a daily cross. With %K still well below 80, the oscillator has room to run before overbought conditions become a factor. Paired with the weekly RSI in #6, both higher-timeframe oscillators have reset and are turning up together. Set against the daily MACD crossover at zero, that is genuine multi-timeframe confluence, and when daily and weekly agree, the signal carries more weight than either alone.
Risks to Consider
Even strong setups can fail, especially in a high-momentum AI optics name like Coherent. A few things could knock the stock off course:
- A breakdown below the symmetrical triangle’s lower trendline and the $287.79 weekly support area on heavy volume would invalidate the bullish setup β and with the pattern not yet resolved to the upside, a failed push at the upper trendline is a real possibility
- Negative company-specific news, broader market weakness, or a rotation out of AI infrastructure names could pressure the stock β and with a beta of roughly 2.10, COHR tends to swing about twice as hard as the overall market in both directions
- Weak cash conversion β despite surging earnings, FY2026 operating cash flow was just $79.5 million against capex of $1.103 billion, for free cash flow of roughly β$1.02 billion, while inventory jumped to $2.581 billion from $1.438 billion and debt stands near $3.22 billion
- Valuation premium β at about 33.9x FY2027 consensus EPS (Stock Analysis), the stock leaves limited room for customer delays or softer growth, and the sharp October 1 repricing raises the odds of a short-term pullback
- Supply-chain risk β China’s export controls on indium phosphide, imposed in February 2025, create availability, qualification, and cost risks; Coherent is expanding internal production, but that doesn’t eliminate its dependence on upstream inputs
- Competition and timing β Lumentum competes in lasers and integrated optics, Chinese suppliers remain major module competitors, and customer qualification delays or a slower shift to CPO/NPO could defer the payoff on Coherent’s manufacturing investment
- Insider selling β CTO Julie Sheridan Eng sold 13,077 shares for roughly $3.58 million across August 31 and September 1 under a pre-arranged trading plan; CFO Sherri Luther’s August 28 filing reflected tax withholding rather than an open-market sale β routine, but worth monitoring
- Policy and positioning uncertainty β the Chinese-transceiver bill is only proposed and could stall or be watered down, while ChartExchange showed 10.178 million shares sold short as of September 15 (another aggregator shows 6.54 million), a sign that a meaningful group of traders is betting against the stock
The Bottom Line
COHR is pressing against the upper boundary of a four-month symmetrical triangle on the daily chart while holding above a key resistance-turned-support level on the weekly β a dual-timeframe technical setup that historically signals the start of a sustained move higher.
The fundamental story underneath the chart is just as strong: a new AI optics platform with 25-plus customer engagements, a multibillion-dollar NVIDIA purchase commitment, and record Q4 revenue up 33.8% YoY.
Combine that with multiple catalysts staggered through the rest of 2026 and into 2027 β Q1 earnings in early November, the PhotonLink revenue ramp in Q4, confirmation of the InP capacity doubling, progress on the proposed Chinese-transceiver bill, and management’s target of a first $3 billion-plus quarter by June 2027 β and COHR looks like one of the more compelling risk-reward setups on the board right now.
If this is a trade you want to get in on, here’s how we’d play it. Below you’ll find our two entry options, both price targets that imply 12%β30% potential upside, and the stop-losses we’re using to manage the downside.
Recommended Trade Setup
Because COHR is pressing right up against the top of its triangle but hasn’t cleared it yet, we’re laying out two ways to play this setup β a breakout entry for traders who want confirmation, and a pullback entry for those who’d rather buy closer to support.
Option 1: Buy on Breakout
| Item | Detail |
|---|---|
| Buy Level | Above approximately $331.00 |
| Price Target 1 | $370.00 β Potential upside: 12% |
| Price Target 2 | $400.00 β Potential upside: 21% |
| Timeframe | Next 3β6 months |
| Stop-Loss | $309.00 on a closing basis |
| Trade Invalidation | Void if price hits stop-loss before entry triggers |
If needed, swipe or scroll sideways to view the full table.
For a risk of approximately $22.00 per share, the target rewards are about $39.00 and $69.00 per share. That makes this roughly a 1:2 and 1:3 risk-reward trade. In other words, the setup offers nearly 2x to 3x more potential upside than downside.
Note on Trade Invalidation: This recommendation stays active as long as the technical structure holds. If COHR drops to or below the $309.00 stop-loss before the $331.00 entry triggers, the breakout trade is automatically void β the support underpinning the thesis would have broken, and the risk-reward setup would no longer justify entry. A pullback toward $308.00 would instead bring Option 2 into play.
Option 2: Buy on Pullback
| Item | Detail |
|---|---|
| Buy Level | On pullback to approximately $308.00 |
| Price Target 1 | $370.00 β Potential upside: 20% |
| Price Target 2 | $400.00 β Potential upside: 30% |
| Timeframe | Next 3β6 months |
| Stop-Loss | $278.00 on a closing basis |
If needed, swipe or scroll sideways to view the full table.
For a risk of approximately $30.00 per share, the target rewards are about $62.00 and $92.00 per share. That makes this roughly a 1:2 and 1:3 risk-reward trade. In other words, the setup offers nearly 2x to 3x more potential upside than downside.
Happy Trading!
Tara and Greg
π₯ Almost Made the Cut
Today’s featured trade, Coherent Corp. (NYSE: COHR), was our top pick of several breakout candidates we evaluated. The following two stocks were strong candidates that made it to the final round β they came up just short of the top spot, but remain on our watchlist and could be featured soon:
Synopsys, Inc. (NASDAQ: SNPS) β The leader in chip-design software delivered a powerful re-rating at its Investor Day, raising its long-term outlook alongside a $1 billion-plus AI chip-design deal with Amazon Web Services, a revenue-share partnership with OpenAI, and roughly $1 billion in planned buybacks. Shares reclaimed their 200-day moving average on the heaviest volume in months, but after a 13% single-day surge into overhead resistance, a better entry may come on a pullback.
ACM Research, Inc. (NASDAQ: ACMR) β The semiconductor cleaning and packaging equipment maker recently disclosed a record backlog of about $2.4 billion (up 88% year over year), driven by China’s chip-tool localization push and AI-related advanced-packaging demand. The stock has carved a constructive higher low on long-term uptrend support and reclaimed its 50-day moving average β China exposure adds geopolitical risk, but a decisive move above resistance in the mid-$90s could reignite its uptrend as earnings approach.


